## AIZ: Assurant, Inc. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.5% in lower entry zone (3.0-6.0%), top 7% cross-sectional ranking. Short-term MRS_5 (0.1%) confirms momentum alignment. Caution: momentum weakening (-2.0% MRS), overbought RSI (75).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($230.78)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 5, Bearish: 1)

**1. Precision Trading with Assurant Inc. 5.25% Subordinated Notes Due 2061 (AIZN) Risk Zones**
- Source: Stock Traders Daily | 20251218T200827 | Neutral | Relevance: 100%
- This article provides a detailed analysis of Assurant Inc. 5.25% Subordinated Notes Due 2061 (AIZN), highlighting a neutral sentiment across all horizons and a significant 12.3:1 risk-reward setup. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis and AI-generated signals for potential traders. The report emphasizes the current price action within a mid-channel oscillation pattern, suggesting a wait-and-see approach.

**2. Assurant, Inc. (AIZ) Hits Fresh High: Is There Still Room to Run?**
- Source: sharewise.com | 20251217T190742 | Bullish | Relevance: 100%
- Assurant (AIZ) recently reached a new 52-week high of $233.38, driven by consistent earnings beats and a strong outlook for future growth. The company holds a Zacks Rank of #2 (Buy) and high Style Scores for Value and Momentum, suggesting continued potential. Its valuation metrics are favorable, outperforming industry peers in some aspects.

**3. Assurant, Inc. (NYSE:AIZ) Given Average Recommendation of "Moderate Buy" by Analysts**
- Source: MarketBeat | 20251218T070621 | Bullish | Relevance: 100%
- Assurant, Inc. (NYSE:AIZ) has received a "Moderate Buy" consensus from ten analysts, with an average 12-month price target of $250.00. The company recently reported Q3 results of $1.80 EPS on $2.42 billion revenue and set FY-2022 guidance, while its board increased the quarterly dividend to $0.88 per share. Institutional investors own approximately 92.7% of the stock, and the company's CEO recently sold a portion of his shares.

**4. Is Assurant Stock Underperforming the Nasdaq?**
- Source: Markets Financial Content | 20251217T120755 | Bullish | Relevance: 100%
- Assurant, Inc. (AIZ) has shown mixed performance compared to the Nasdaq Composite ($NASX). While AIZ stock gained 13.6% in the past three months, outperforming NASX’s 3.5%, it underperformed in the longer term with 7.4% gains over 52 weeks against NASX's 14.6%. Analysts maintain a "Moderate Buy" rating for AIZ, projecting an 8.7% upside.

**5. Assessing Assurant (AIZ) Valuation After a Steady Multi-Year Share Price Climb**
- Source: Yahoo Finance | 20251218T140742 | Bullish | Relevance: 100%
- Assurant (AIZ) has seen its stock price double over three years and is up 16% in the past year, trading just below analyst targets. The company is considered 6.6% undervalued with a narrative fair value near $253.67, driven by investments in AI, automation, and digital platforms leading to operational efficiencies and margin expansion. However, risks include potential regulatory pressure and intensifying digital competition in mobile device protection.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Piper Sandler | $264 | $252 | +5% |
| 2025-11-20 | Keefe, Bruyette | $254 | $248 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Piper Sandler | main | Overweight |
| 2025-11-20 | Keefe, Bruyette | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.10M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-2.0%)
- Bank Of New York Mel: 10.0% (+23.7%)
- Blackrock Inc.: 7.9% (-0.4%)
- T. Rowe Price Invest: 7.7% (-3.5%)
- State Street Corpora: 5.4% (-3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Balance sheet: strong liquidity (11492000000.0x). Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $12.1B |
| Beta | 0.57 |
| 52W Range | $174.97 - $240.58 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 11.5 |
| Current P/E | 12.2 |
| YoY Growth | 6.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 5.5% to 3.5% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 92nd percentile. MRS_5 at 0.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.27), confirming momentum. RSI overbought at 75, risk of mean reversion. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.54% (CS: 93) | Strong |
| RSI_14 | 74.7 | Overbought |
| MACD Histogram | 1.27 | Bullish |
| vs SMA20 | 1.049x | Above |
| vs SMA50 | 1.080x | Above |
| vs SMA200 | 1.157x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $239.12
- **Stop Loss:** $230.78 (3.5% risk)
- **Target:** $251.63 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 107
- **Position Value:** $25,585.84
- **Portfolio %:** 25.59%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-10 (Est: $5.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.28 | $5.73 | +34.0% |
| 2025Q2 | $4.45 | $5.10 | +14.5% |
| 2025Q1 | $2.78 | $3.39 | +22.1% |
| 2024Q4 | $4.13 | $4.79 | +15.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*